Past Fund-A-Need Beneficiaries
2015 - Cancer Patient Support Services and Cancer Research
Benefiting Scripps Cancer Patient Support Services and Cancer Research at Scripps
2014 - Patient Support Services and Lung Care Initiatve
Benefiting Scripps Cancer Patient Support Services and Our New Lung Cancer Initiative
2013 - Mobetron
Mobetron is the world's first mobile, self-shielded electron linear accelerator that delivers intraoperative electron radiotherapy (IOERT) directly to a tumor site — safely and efficiently — as a patient is undergoing cancer surgery. This enables the surgical oncologist and the radiation oncologist to visually pinpoint the optimal site for radiation and help avoid irradiating much of the healthy tissue. As a breast cancer treatment, it is ideal for many lumpectomy patients who could receive part or all of their radiation therapy in the operating room, avoiding weeks of follow up radiation therapy. Clinical trials have shown that patients treated with IOERT often have fewer recurrences of cancer, which correlates to increased survival.
2012 - Polster Breast Care Center IOERT
As a breast cancer treatment, IOERT is ideal for many lumpectomy patients who could receive part of all of their radiation therapy in the operating room. This helps avoid 5-8 weeks of post-operative radiation therapy.
2011 - John S. Trombold Endowment
This permanent fund was set up in honor of John S. Trombold, MD, and will build financial security for the patient services programs he worked so hard to establish over the years. Attendees helped establish his legacy through the John S. Trombold Endowment for Patient Services by donating cash or planned gifts.
2010 - Minimally Invasive Surgery Program
In 2010, the fund-an-item portion of the event supported minimally invasive surgery program at Scripps Memorial Hospital La Jolla. The program included upgraded minimally invasive surgical equipment, as well as the design and construction of a state-of-the-art surgical suite complete with leading-edge video integration technology. For patients with cancer, these surgical procedures are less invasive, which result in shorter hospital stays and quicker recoveries.
2009 - da Vinci Robotic Surgical System
In 2009, the fund-an-item portion of the event purchased a da Vinci® Robotic Surgical System for use in surgery for treatment of various cancers. Robot-assisted surgery is performed through tiny incisions of one-to-two centimeters and with minimal impact to the surrounding area. The robotic surgical system provides surgeons with enhanced dexterity, precision and control, offering greater range of motion than the human hand and wrist. As a result, patients typically experience less blood loss, less risk of infection, less pain and scarring, and a quicker recovery.